Clinical Trial Update: Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation [Phase 1]

View source ↗

Summary

This update describes a Phase 1 study evaluating NV1FGF for tolerability and gene expression in patients with Peripheral Arterial Occlusive Disease undergoing m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Occlusive Disease

Drugs mentioned

• NV1FGF (NV1FGF)

Snippet

Sponsor: Sanofi | Conditions: Peripheral Arterial Occlusive Disease | Phase 1 | Status: COMPLETED